Christopher Henry, MD
Surgery · Oklahoma City, OKNPI 1265846349
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (54.4%), grants and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 62.0% of it on its own, with 39 other manufacturers making up the rest. Among surgery clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 228 payments — averaging $70.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$10K
- W. L. Gore & Associates, Inc.$2K
- Silk Road Medical, Inc.$930
- Bard Peripheral Vascular, Inc.$634
- Axogen$493
- Bolton Medical Inc$228
- plus $2K from 34 others
What the payments were for
- Grants$6,67241%
- Travel & lodging$3552%
- Food & beverage$8,80454%
- Education$3402%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 59 | $10,032 |
| W. L. Gore & Associates, Inc. | 47 | $2,070 |
| Silk Road Medical, Inc. | 9 | $930 |
| Bard Peripheral Vascular, Inc. | 15 | $634 |
| Axogen | 21 | $493 |
| Bolton Medical Inc | 3 | $228 |
| Tactile Systems Technology Inc | 12 | $204 |
| Cook Medical LLC | 1 | $172 |
| Johnson & Johnson(2 entities) | 8 | $141 |
| Cvrx, Inc. | 5 | $123 |
| Stryker | 5 | $120 |
| AbbVie | 5 | $106 |
| Boston Scientific | 1 | $79 |
| Endologix LLC | 1 | $69 |
| Penumbra, Inc. | 2 | $62 |
| Ossur Americas, Inc. | 2 | $52 |
| Inari Medical, Inc. | 3 | $52 |
| Shockwave Medical, Inc | 2 | $51 |
| Baylis Medical Technologies Inc. | 1 | $50 |
| Resmed Corp | 2 | $46 |
| Kerecis Limited | 2 | $41 |
| Pfizer | 2 | $40 |
| Teleflex LLC | 2 | $38 |
| E.r. Squibb & Sons, L.L.C. | 2 | $32 |
| Actelion Pharmaceuticals US, Inc. | 1 | $31 |
| Angiodynamics, Inc. | 1 | $28 |
| Boehringer Ingelheim | 1 | $25 |
| Novartis | 1 | $22 |
| GE HealthCare | 1 | $21 |
| Cashflow Solutions, LLC | 1 | $21 |
| Acist Medical Systems, Inc. | 1 | $20 |
| BD | 1 | $19 |
| Masimo Corporation | 1 | $18 |
| Portola Pharmaceuticals, LLC | 1 | $16 |
| Integra Lifesciences Corporation | 1 | $16 |
| Alafair Biosciences, Inc. | 1 | $15 |
| Smith+Nephew | 1 | $15 |
| Avinger Inc. | 1 | $14 |
| KCI USA, Inc. | 1 | $13 |
| AstraZeneca | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Endurant$6,500
- ENDURANT IIS$1,213
- ENROUTE Transcarotid Stent$797
- ENROUTE Transcarotid Neuroprotection System$797
- ENHANCE Transcarotid Peripheral Access Kit$629
- ENROUTE .014 Guidewire$629
- Heli-FX EndoAnchor System$337
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$294
- GORE VIABAHN VBX Balloon Expandable Endo$283
- Abre$252
- GORE EXCLUDER Iliac Branch Endoprosthesis$181
- RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM$177
- THORAFLEX HYBRID$177
- Resolute$163
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$158
- Lutonix Drug Coated Balloon$151
- GORE TAG Thoracic Endoprosthesis$147
- VIABAHN Endoprosthesis$140
- GORE VIABAHN Endoprosthesis with Heparin$134
- SYNECOR Biomaterial$128
How this compares
$16,171 in reported general payments places this provider in the 90th percentile of 290 surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 12 | $6,695 |
| ClopidogrelClopidogrel Bisulfate | 42 | $692 |
| Tramadol Hcl | 20 | $54 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $141 | $6,69512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 290 surgery providers in Oklahoma.
Other surgery in Oklahoma City
- Christopher CareyOklahoma City$39K
- Alexander RainesOklahoma City$36K
- Brian HerrittOklahoma City$12K
- Carson AgeeOklahoma City$11K
- Marcia MooreOklahoma City$11K
- Joseph BuendiaOklahoma City$11K
- Laura FischerOklahoma City$11K
- James ShepherdOklahoma City$10K
- Peter CollisterOklahoma City$10K
- Dayne JensenOklahoma City$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.